Format

Send to

Choose Destination
J Pediatr Endocrinol Metab. 2009 Feb;22(2):171-5.

Extended-release glipizide overdose presenting with delayed hypoglycemia and treated with subcutaneous octreotide.

Author information

1
Department of Pediatrics, Valley Health System, The Valley Hospital, Ridgewood, NJ, USA.

Abstract

The onset of symptomatic hypoglycemia in children with ingestions of second-generation sulfonylureas has never been documented to be later than 21 hours post-ingestion. We report a case with the longest known interval, 45 hours, between ingestion of a sulfonylurea and the onset of hypoglycemia requiring medical intervention. The hypoglycemia was severe and required multiple dextrose boluses in addition to continuous dextrose infusion for 36 hours. This patient was also treated with multiple doses of subcutaneous octreotide because of persistent hypoglycemia despite the above management. This case represents the first report of subcutaneous octreotide used as a treatment for pediatric hypoglycemia secondary to sulfonylurea exposure.

PMID:
19449674
PMCID:
PMC3810394
DOI:
10.1515/jpem.2009.22.2.171
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Sheridan PubFactory Icon for PubMed Central
Loading ...
Support Center